NK cells could eliminate tumor cells through CD16-mediated antibody-dependent cell-mediated cytotoxicity (ADCC), direct target killing by cytolytic granules, (e.g. perforin and granzymes), or via engagement of death receptors (e.g. FASL or TRAIL) (30). The gene discussed is FASLG; the disease is neoplasm.